Immunization therapy in Alzheimer's disease

Felix Mor, Alon Monsonego

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-β peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.

Original languageEnglish
Pages (from-to)653-659
Number of pages7
JournalExpert Review of Neurotherapeutics
Issue number5
StatePublished - 4 Jul 2006


  • Alzheimer's disease
  • Clinical trials
  • Meningoencephalitis
  • Th1/Th2 balance
  • Vaccination

ASJC Scopus subject areas

  • General Neuroscience
  • Clinical Neurology
  • Pharmacology (medical)


Dive into the research topics of 'Immunization therapy in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this